A prospective, multicenter registry of high-risk patients treated with Umirolimus stent [Nobori]

Trial Profile

A prospective, multicenter registry of high-risk patients treated with Umirolimus stent [Nobori]

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms INSPIRE-1
  • Most Recent Events

    • 30 Aug 2017 Results comparing 1 year stent-related clinical outcomes of coronary Amphilimus-eluting stent versus biodegradable-polymer Biolimus-eluting stent from this and ASTUTE registry, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 15 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top